In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback